Page last updated: 2024-10-27

flufenamic acid and Sepsis

flufenamic acid has been researched along with Sepsis in 1 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research Excerpts

ExcerptRelevanceReference
"Investigate the effect of flufenamic acid (FFA) on lung injury of sepsis rats."7.96Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. ( Chen, Z; Jiang, H; Jiang, Q, 2020)
"Investigate the effect of flufenamic acid (FFA) on lung injury of sepsis rats."3.96Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. ( Chen, Z; Jiang, H; Jiang, Q, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jiang, Q1
Chen, Z1
Jiang, H1

Other Studies

1 other study available for flufenamic acid and Sepsis

ArticleYear
Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1.
    Drug development research, 2020, Volume: 81, Issue:7

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Carbonyl Reductase (NADPH); Cell Line; Flufena

2020